PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
Recruiting · NCT04099134 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Ulm
View the official record on ClinicalTrials.gov →What this trial is about
PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
- Age =\>18 years
- written informed consent
Exclusion criteria
- papillary cancer
- neuroendocrine pancreatic tumors
Where it is running
1 location listed.
- Universitätsklinikum Ulm - Ulm, Germany